escin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
2956 6805-41-0

Description:

MoleculeDescription

Synonyms:

  • escin
  • aescin
  • aescine
  • aescusan
  • escusan
Pentacyclic triterpene saponins, biosynthesized from protoaescigenin and barringtogenol, occurring in the seeds of AESCULUS. It inhibits edema formation and decreases vascular fragility.
  • Molecular weight:
  • Formula:
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
MeSH PA D002317 Cardiovascular Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
N0000168475 NUI
D07912 KEGG_DRUG
C0014838 UMLSCUI
CHEBI:2500 CHEBI
CHEMBL4594473 ChEMBL_ID
CHEMBL1159567 ChEMBL_ID
CHEMBL2109073 ChEMBL_ID
D004928 MESH_DESCRIPTOR_UI
DB15907 DRUGBANK_ID
RUU8G67GQM UNII
6476031 PUBCHEM_CID
4065 RXNORM
005569 NDDF
702951009 SNOMEDCT_US
83055002 SNOMEDCT_US

Pharmaceutical products:

None